Design, synthesis and evaluation of novel hydroxyamides as orally available anticonvulsants
作者:Hilary A Schenck、Paul W Lenkowski、Indrani Choudhury-Mukherjee、Seong-Hoon Ko、James P Stables、Manoj K Patel、Milton L Brown
DOI:10.1016/j.bmc.2003.12.011
日期:2004.3
Themisone, also known as Atrolactamide, was found, in the 1950s, to be a very potent anticonvulsant. It was hypothesized that the -CF(3) substitution would maintain the anticonvulsant activity. Anticonvulsant testing of our novel compounds by the National Institute of Health's Anticonvulsant Screening Project of the Antiepileptic Drug Discovery Program identified analogue 1, 3,3,3-trifluoro-2-hydr
在1950年代,Themisone也被称为Atrolactamide,是一种非常有效的抗惊厥药。假设-CF(3)取代将维持抗惊厥活性。由美国国立卫生研究院抗癫痫药物发现计划的抗惊厥药物筛选项目对我们的新化合物进行的抗惊厥试验确定类似物1,3,3,3-三氟-2-羟基-2-羟基-2-苯基-丙酰胺具有有效的抗惊厥活性(MES ED(50)为9.9 mg / kg,ScMET ED(50)为34 mg / kg和TD(50)为100 mg / kg)。因此,利用多种合成途径合成了各种各样的类似物,以探索结构-活性关系。膜片钳电生理实验表明,化合物1是有效的T型钙通道阻滞剂。共,